Selected Publications
Jones, Brandon; Lee, Hyunyeol; Cheng, Cheng-Chieh; Al Mukaddam, Mona; Song, Hee Kwon; Snyder, Peter; Kamona, Nada; Rajapakse, Chamith; Wehrli, Felix: MRI Quantification of Cortical Bone Porosity, Mineralization, and Morphology in Postmenopausal Osteoporosis Radiology : 2023.
Pignolo RJ, Hsiao EC, Al Mukaddam M, Baujat G, Berglund SK, Brown MA, Cheung AM, De Cunto C, Delai P, Haga N, Kannu P, Keen R, Le Quan Sang KH, Mancilla EE, Marino R, Strahs A, Kaplan FS: Reduction of New Heterotopic Ossification (HO) in the Open-Label, Phase 3 MOVE Trial of Palovarotene for Fibrodysplasia Ossificans Progressiva (FOP) J Bone Miner Res : 2022.
Al Mukaddam M, Toder KS, Davis M, Cali A, Liljesthröm M, Hollywood S, Croskery K, Grandoulier AS, Böing EA, Whalen JD, Kaplan FS.: The impact of fibrodysplasia ossificans progressiva (FOP) on patients and their family members: results from an international burden of illness survey. Expert Rev Pharmacoecon Outcomes Res : 2022.
Pignolo RJ, Baujat G, Brown MA, De Cunto C, Hsiao EC, Keen R, Al Mukaddam M, Le Quan Sang KH, Wilson A, Marino R, Strahs A, Kaplan FS: The natural history of fibrodysplasia ossificans progressiva: A prospective, global 36-month study Genet Med : 2022.
Mona Al Mukaddam, Katherine S. Toder, Michelle Davis, , Amanda Cali, Moira Liljesthröm, Suzanne Hollywood, Kim Croskery, Anne-Sophie Grandoulier, Elaine A. Böing, Jan Swiderski, John D. Whalen, Frederick S. Kaplan: Using a Patient-Centric Approach to Understand the Impact of Fibrodysplasia Ossificans Progressiva (FOP) in an International Burden of Illness Survey Oral Presentation at the FOP Drug Development Forum : 2022.
Robert J. Pignolo, Edward C. Hsiao, Mona Al Mukaddam, Geneviève Baujat, Staffan K. Berglund, Matthew A. Brown, Angela M. Cheung, Carmen De Cunto, Patricia Delai, Nobuhiko Haga, Peter Kannu, Richard Keen, Kim-Hanh Le Quan Sang, Edna E. Mancilla, Rose Marino, Andrew Strahs, Frederick S. Kaplan: Reduction of New HO in the Open-Label, Phase 3 MOVE Trial of Palovarotene for Fibrodysplasia Ossificans Progressiva Oral Presentation at the FOP Drug Development Forum : 2022.
Mona Al Mukaddam, Katherine S. Toder, Michelle Davis, Kim Croskery, Anne-Sophie Grandoulier, Elaine A. Böing, Frederick S. Kaplan: Joint Function and Quality of Life in Fibrodysplasia Ossificans Progressiva: Results from an International Burden of Illness Survey of Patients and Family Members Poster Presentation at ASBMR annual meeting : 2022.
Robert J. Pignolo, Geneviève Baujat, Carmen De Cunto, Edward C. Hsiao, Richard Keen, Mona Al Mukaddam, Rose Marino, Elaine A. Böing, Anne-Sophie Grandoulier, Frederick S. Kaplan: Association of Heterotopic Ossification with Use of Aids, Assistive Devices, and Adaptations in Individuals with Fibrodysplasia Ossificans Progressiva Poster Presentation at ASBMR annual meeting : 2022.
Farzana A. Sayani, Ashutosh Lal, Gregory E. Tasian, Mona Al Mukaddam, David W. Killilea, Ellen B. Fung: Kidney Stones in Transfusion-Dependent Thalassemia: Prevalence and Risk Factors Open Journal of Urology 12 (4): 209-227,2022.
Kaplan, F. S., Groppe, J. C., Xu, M., Towler, O. W., Grunvald, E., Kalunian, K., Kallish, S., Al Mukaddam, M., Pignolo, R. J., & Shore, E. M.: An ACVR1R375P pathogenic variant in two families with mild fibrodysplasia ossificans progressiva. American Journal of Medical Genetics Part A : 1-12,2022.
Academic Contact Information
3rd floor Penn Medicine University City
3737 Market Street
Philadelphia,
PA
19104
Phone: 215-662-9905
Patient appointments: 800-789-7366